APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Veterinary Therapeutics Market Analysis and Forecast 2026-2032

21 December 2025208 pages

Choose your research edition.

Industry ResearchVeterinary Therapeutics Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Therapeutics Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Veterinary Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Therapeutics Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Therapeutics Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Veterinary Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Veterinary Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Veterinary Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Veterinary Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Veterinary Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Veterinary Therapeutics include CAHIC, Zoetis, Ringpu Biology, Merck, Virbac, Vetoquinol, Phibro, Ouro Fino Saude and Orion, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Veterinary Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Veterinary Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Veterinary Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Veterinary Therapeutics Segment by Company

CAHIC

Zoetis

Ringpu Biology

Merck

Virbac

Vetoquinol

Phibro

Ouro Fino Saude

Orion

Norbrook

Nippon Zenyaku Kogyo

Huvepharma

Hipra

Farmavet-Pasteur

Elanco

Dechra

Ceva

Boehringer Ingelheim

Veterinary Therapeutics Segment by Type

Analgesics

Sedatives

Anti-Inflammatory

Parasiticides

Anti-Infectives

Others

Veterinary Therapeutics Segment by Application

Swine

Cattle

Poultry

Pets

Others

Veterinary Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Veterinary Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Veterinary Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Therapeutics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Analgesics Major Player Table 3. Sedatives Major Player Table 4. Anti-Inflammatory Major Player Table 5. Parasiticides Major Player Table 6. Anti-Infectives Major Player Table 7. Others Major Player Table 8. Global Veterinary Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Swine Major Player Table 10. Cattle Major Player Table 11. Poultry Major Player Table 12. Pets Major Player Table 13. Others Major Player Table 14. Veterinary Therapeutics Industry Trends Table 15. Veterinary Therapeutics Industry Drivers Table 16. Veterinary Therapeutics Industry Opportunities and Challenges Table 17. Veterinary Therapeutics Industry Restraints Table 18. Global Veterinary Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 19. Global Veterinary Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 20. Global Veterinary Therapeutics Market Share by Region (2021-2026) Table 21. Global Veterinary Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 22. Global Veterinary Therapeutics Market Share by Region (2027-2032) Table 23. Global Veterinary Therapeutics Revenue by Players (US$ Million) & (2021-2026) Table 24. Global Veterinary Therapeutics Revenue Market Share by Players (2021-2026) Table 25. Global Veterinary Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026 Table 26. Global Veterinary Therapeutics Key Players Headquarters & Area Served Table 27. Global Veterinary Therapeutics Players, Product Type & Application Table 28. Global Veterinary Therapeutics Players Establishment Date Table 29. Global Players Market Concentration Ratio (CR5 and HHI) Table 30. Global Veterinary Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 31. Global Veterinary Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Veterinary Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 33. Global Veterinary Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 34. Global Veterinary Therapeutics Revenue Market Share by Type (2021-2026) Table 35. Global Veterinary Therapeutics Revenue Market Share by Type (2027-2032) Table 36. Global Veterinary Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Veterinary Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 38. Global Veterinary Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 39. Global Veterinary Therapeutics Revenue Market Share by Application (2021-2026) Table 40. Global Veterinary Therapeutics Revenue Market Share by Application (2027-2032) Table 41. CAHIC Company Information Table 42. CAHIC Business Overview Table 43. CAHIC Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. CAHIC Veterinary Therapeutics Product Portfolio Table 45. CAHIC Recent Development Table 46. Zoetis Company Information Table 47. Zoetis Business Overview Table 48. Zoetis Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Zoetis Veterinary Therapeutics Product Portfolio Table 50. Zoetis Recent Development Table 51. Ringpu Biology Company Information Table 52. Ringpu Biology Business Overview Table 53. Ringpu Biology Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Ringpu Biology Veterinary Therapeutics Product Portfolio Table 55. Ringpu Biology Recent Development Table 56. Merck Company Information Table 57. Merck Business Overview Table 58. Merck Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Merck Veterinary Therapeutics Product Portfolio Table 60. Merck Recent Development Table 61. Virbac Company Information Table 62. Virbac Business Overview Table 63. Virbac Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Virbac Veterinary Therapeutics Product Portfolio Table 65. Virbac Recent Development Table 66. Vetoquinol Company Information Table 67. Vetoquinol Business Overview Table 68. Vetoquinol Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Vetoquinol Veterinary Therapeutics Product Portfolio Table 70. Vetoquinol Recent Development Table 71. Phibro Company Information Table 72. Phibro Business Overview Table 73. Phibro Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Phibro Veterinary Therapeutics Product Portfolio Table 75. Phibro Recent Development Table 76. Ouro Fino Saude Company Information Table 77. Ouro Fino Saude Business Overview Table 78. Ouro Fino Saude Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Ouro Fino Saude Veterinary Therapeutics Product Portfolio Table 80. Ouro Fino Saude Recent Development Table 81. Orion Company Information Table 82. Orion Business Overview Table 83. Orion Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Orion Veterinary Therapeutics Product Portfolio Table 85. Orion Recent Development Table 86. Norbrook Company Information Table 87. Norbrook Business Overview Table 88. Norbrook Veterinary Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Norbrook Veterinary Therapeutics Product Portfolio Table 90. Norbrook Recent Development Table 91. Nippon Zenyaku Kogyo Company Information Table 92. Nippon Zenyaku Kogyo Business Overview Table 93. Nippon Zenyaku Kogyo Veterinary Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Nippon Zenyaku Kogyo Veterinary Therapeutics Product Portfolio Table 95. Nippon Zenyaku Kogyo Recent Development Table 96. Huvepharma Company Information Table 97. Huvepharma Business Overview Table 98. Huvepharma Veterinary Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Huvepharma Veterinary Therapeutics Product Portfolio Table 100. Huvepharma Recent Development Table 101. Hipra Company Information Table 102. Hipra Business Overview Table 103. Hipra Veterinary Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Hipra Veterinary Therapeutics Product Portfolio Table 105. Hipra Recent Development Table 106. Farmavet-Pasteur Company Information Table 107. Farmavet-Pasteur Business Overview Table 108. Farmavet-Pasteur Veterinary Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Farmavet-Pasteur Veterinary Therapeutics Product Portfolio Table 110. Farmavet-Pasteur Recent Development Table 111. Elanco Company Information Table 112. Elanco Business Overview Table 113. Elanco Veterinary Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Elanco Veterinary Therapeutics Product Portfolio Table 115. Elanco Recent Development Table 116. Dechra Company Information Table 117. Dechra Business Overview Table 118. Dechra Veterinary Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Dechra Veterinary Therapeutics Product Portfolio Table 120. Dechra Recent Development Table 121. Ceva Company Information Table 122. Ceva Business Overview Table 123. Ceva Veterinary Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Ceva Veterinary Therapeutics Product Portfolio Table 125. Ceva Recent Development Table 126. Boehringer Ingelheim Company Information Table 127. Boehringer Ingelheim Business Overview Table 128. Boehringer Ingelheim Veterinary Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Boehringer Ingelheim Veterinary Therapeutics Product Portfolio Table 130. Boehringer Ingelheim Recent Development Table 131. North America Veterinary Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 132. North America Veterinary Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 133. North America Veterinary Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 134. North America Veterinary Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 135. North America Veterinary Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Veterinary Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 137. North America Veterinary Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 138. Europe Veterinary Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 139. Europe Veterinary Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 140. Europe Veterinary Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 141. Europe Veterinary Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 142. Europe Veterinary Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Veterinary Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 144. Europe Veterinary Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 145. China Veterinary Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 146. China Veterinary Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 147. China Veterinary Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 148. China Veterinary Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Veterinary Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 150. Asia Veterinary Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 151. Asia Veterinary Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 152. Asia Veterinary Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 153. Asia Veterinary Therapeutics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia Veterinary Therapeutics Revenue by Region (US$ Million) & (2021-2026) Table 155. Asia Veterinary Therapeutics Revenue by Region (US$ Million) & (2027-2032) Table 156. SAMEA Veterinary Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 157. SAMEA Veterinary Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 158. SAMEA Veterinary Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 159. SAMEA Veterinary Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 160. SAMEA Veterinary Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. SAMEA Veterinary Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 162. SAMEA Veterinary Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Veterinary Therapeutics Image Figure 2. Global Veterinary Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Analgesics Image Figure 5. Sedatives Image Figure 6. Anti-Inflammatory Image Figure 7. Parasiticides Image Figure 8. Anti-Infectives Image Figure 9. Others Image Figure 10. Global Veterinary Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Veterinary Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 12. Swine Image Figure 13. Cattle Image Figure 14. Poultry Image Figure 15. Pets Image Figure 16. Others Image Figure 17. Global Veterinary Therapeutics Market Size (US$ Million) & (2021-2032) Figure 18. Global Veterinary Therapeutics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Veterinary Therapeutics Market Share by Region: 2021 VS 2025 VS 2032 Figure 20. Global Veterinary Therapeutics Players Revenue Share Top 10 and Top 5 in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Veterinary Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Veterinary Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Veterinary Therapeutics Revenue Market Share by Type (2021-2032) Figure 25. Global Veterinary Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Veterinary Therapeutics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 27. Global Veterinary Therapeutics Revenue Market Share by Application (2021-2032) Figure 28. North America Veterinary Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. North America Veterinary Therapeutics Revenue Share by Type (2021-2032) Figure 30. North America Veterinary Therapeutics Revenue Share by Application (2021-2032) Figure 31. North America Veterinary Therapeutics Revenue Share by Country (2021-2032) Figure 32. United States Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Canada Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Mexico Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Europe Veterinary Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 36. Europe Veterinary Therapeutics Revenue Share by Type (2021-2032) Figure 37. Europe Veterinary Therapeutics Revenue Share by Application (2021-2032) Figure 38. Europe Veterinary Therapeutics Revenue Share by Country (2021-2032) Figure 39. Germany Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. France Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. U.K. Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Italy Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Spain Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Russia Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Netherlands Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Nordic Countries Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. China Veterinary Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. China Veterinary Therapeutics Revenue Share by Type (2021-2032) Figure 49. China Veterinary Therapeutics Revenue Share by Application (2021-2032) Figure 50. Asia Veterinary Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 51. Asia Veterinary Therapeutics Revenue Share by Type (2021-2032) Figure 52. Asia Veterinary Therapeutics Revenue Share by Application (2021-2032) Figure 53. Asia Veterinary Therapeutics Revenue Share by Region (2021-2032) Figure 54. Japan Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. South Korea Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. India Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Australia Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Taiwan Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Southeast Asia Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. SAMEA Veterinary Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 61. SAMEA Veterinary Therapeutics Revenue Share by Type (2021-2032) Figure 62. SAMEA Veterinary Therapeutics Revenue Share by Application (2021-2032) Figure 63. SAMEA Veterinary Therapeutics Revenue Share by Country (2021-2032) Figure 64. Brazil Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Argentina Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Chile Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Colombia Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Peru Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Saudi Arabia Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Israel Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. UAE Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Turkey Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Iran Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Egypt Veterinary Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesics
  • Sedatives
  • Anti-Inflammatory
  • Parasiticides
  • Anti-Infectives
  • Others
Applications
  • Swine
  • Cattle
  • Poultry
  • Pets
  • Others
Companies covered
  • CAHIC
  • Zoetis
  • Ringpu Biology
  • Merck
  • Virbac
  • Vetoquinol
  • Phibro
  • Ouro Fino Saude
  • Orion
  • Norbrook
  • Nippon Zenyaku Kogyo
  • Huvepharma
  • Hipra
  • Farmavet-Pasteur
  • Elanco
  • Dechra
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Veterinary Therapeutics Market by Type
  3. 1.2.1 Global Veterinary Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Analgesics
  5. 1.2.3 Sedatives
  6. 1.2.4 Anti-Inflammatory
  7. 1.2.5 Parasiticides
  8. 1.2.6 Anti-Infectives
  9. 1.2.7 Others
  10. 1.3 Veterinary Therapeutics Market by Application
  11. 1.3.1 Global Veterinary Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Swine
  13. 1.3.3 Cattle
  14. 1.3.4 Poultry
  15. 1.3.5 Pets
  16. 1.3.6 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Veterinary Therapeutics Market Dynamics
  1. 2.1 Veterinary Therapeutics Industry Trends
  2. 2.2 Veterinary Therapeutics Industry Drivers
  3. 2.3 Veterinary Therapeutics Industry Opportunities and Challenges
  4. 2.4 Veterinary Therapeutics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Veterinary Therapeutics Market Perspective (2021-2032)
  2. 3.2 Global Veterinary Therapeutics Growth Trends by Region
  3. 3.2.1 Global Veterinary Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Veterinary Therapeutics Market Size by Region (2021-2026)
  5. 3.2.3 Global Veterinary Therapeutics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Veterinary Therapeutics Revenue by Players
  2. 4.1.1 Global Veterinary Therapeutics Revenue by Players (2021-2026)
  3. 4.1.2 Global Veterinary Therapeutics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Veterinary Therapeutics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Veterinary Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Veterinary Therapeutics Key Players Headquarters & Area Served
  7. 4.4 Global Veterinary Therapeutics Players, Product Type & Application
  8. 4.5 Global Veterinary Therapeutics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Veterinary Therapeutics Market CR5 and HHI
  11. 4.6.3 2025 Veterinary Therapeutics Tier 1, Tier 2, and Tier 3
5 Veterinary Therapeutics Market Size by Type
  1. 5.1 Global Veterinary Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Veterinary Therapeutics Revenue by Type (2021-2032)
  3. 5.3 Global Veterinary Therapeutics Revenue Market Share by Type (2021-2032)
6 Veterinary Therapeutics Market Size by Application
  1. 6.1 Global Veterinary Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Veterinary Therapeutics Revenue by Application (2021-2032)
  3. 6.3 Global Veterinary Therapeutics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 CAHIC
  2. 7.1.1 CAHIC Company Information
  3. 7.1.2 CAHIC Business Overview
  4. 7.1.3 CAHIC Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 CAHIC Veterinary Therapeutics Product Portfolio
  6. 7.1.5 CAHIC Recent Developments
  7. 7.2 Zoetis
  8. 7.2.1 Zoetis Company Information
  9. 7.2.2 Zoetis Business Overview
  10. 7.2.3 Zoetis Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Zoetis Veterinary Therapeutics Product Portfolio
  12. 7.2.5 Zoetis Recent Developments
  13. 7.3 Ringpu Biology
  14. 7.3.1 Ringpu Biology Company Information
  15. 7.3.2 Ringpu Biology Business Overview
  16. 7.3.3 Ringpu Biology Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Ringpu Biology Veterinary Therapeutics Product Portfolio
  18. 7.3.5 Ringpu Biology Recent Developments
  19. 7.4 Merck
  20. 7.4.1 Merck Company Information
  21. 7.4.2 Merck Business Overview
  22. 7.4.3 Merck Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Merck Veterinary Therapeutics Product Portfolio
  24. 7.4.5 Merck Recent Developments
  25. 7.5 Virbac
  26. 7.5.1 Virbac Company Information
  27. 7.5.2 Virbac Business Overview
  28. 7.5.3 Virbac Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Virbac Veterinary Therapeutics Product Portfolio
  30. 7.5.5 Virbac Recent Developments
  31. 7.6 Vetoquinol
  32. 7.6.1 Vetoquinol Company Information
  33. 7.6.2 Vetoquinol Business Overview
  34. 7.6.3 Vetoquinol Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Vetoquinol Veterinary Therapeutics Product Portfolio
  36. 7.6.5 Vetoquinol Recent Developments
  37. 7.7 Phibro
  38. 7.7.1 Phibro Company Information
  39. 7.7.2 Phibro Business Overview
  40. 7.7.3 Phibro Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Phibro Veterinary Therapeutics Product Portfolio
  42. 7.7.5 Phibro Recent Developments
  43. 7.8 Ouro Fino Saude
  44. 7.8.1 Ouro Fino Saude Company Information
  45. 7.8.2 Ouro Fino Saude Business Overview
  46. 7.8.3 Ouro Fino Saude Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Ouro Fino Saude Veterinary Therapeutics Product Portfolio
  48. 7.8.5 Ouro Fino Saude Recent Developments
  49. 7.9 Orion
  50. 7.9.1 Orion Company Information
  51. 7.9.2 Orion Business Overview
  52. 7.9.3 Orion Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Orion Veterinary Therapeutics Product Portfolio
  54. 7.9.5 Orion Recent Developments
  55. 7.10 Norbrook
  56. 7.10.1 Norbrook Company Information
  57. 7.10.2 Norbrook Business Overview
  58. 7.10.3 Norbrook Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Norbrook Veterinary Therapeutics Product Portfolio
  60. 7.10.5 Norbrook Recent Developments
  61. 7.11 Nippon Zenyaku Kogyo
  62. 7.11.1 Nippon Zenyaku Kogyo Company Information
  63. 7.11.2 Nippon Zenyaku Kogyo Business Overview
  64. 7.11.3 Nippon Zenyaku Kogyo Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Nippon Zenyaku Kogyo Veterinary Therapeutics Product Portfolio
  66. 7.11.5 Nippon Zenyaku Kogyo Recent Developments
  67. 7.12 Huvepharma
  68. 7.12.1 Huvepharma Company Information
  69. 7.12.2 Huvepharma Business Overview
  70. 7.12.3 Huvepharma Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Huvepharma Veterinary Therapeutics Product Portfolio
  72. 7.12.5 Huvepharma Recent Developments
  73. 7.13 Hipra
  74. 7.13.1 Hipra Company Information
  75. 7.13.2 Hipra Business Overview
  76. 7.13.3 Hipra Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Hipra Veterinary Therapeutics Product Portfolio
  78. 7.13.5 Hipra Recent Developments
  79. 7.14 Farmavet-Pasteur
  80. 7.14.1 Farmavet-Pasteur Company Information
  81. 7.14.2 Farmavet-Pasteur Business Overview
  82. 7.14.3 Farmavet-Pasteur Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Farmavet-Pasteur Veterinary Therapeutics Product Portfolio
  84. 7.14.5 Farmavet-Pasteur Recent Developments
  85. 7.15 Elanco
  86. 7.15.1 Elanco Company Information
  87. 7.15.2 Elanco Business Overview
  88. 7.15.3 Elanco Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Elanco Veterinary Therapeutics Product Portfolio
  90. 7.15.5 Elanco Recent Developments
  91. 7.16 Dechra
  92. 7.16.1 Dechra Company Information
  93. 7.16.2 Dechra Business Overview
  94. 7.16.3 Dechra Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Dechra Veterinary Therapeutics Product Portfolio
  96. 7.16.5 Dechra Recent Developments
  97. 7.17 Ceva
  98. 7.17.1 Ceva Company Information
  99. 7.17.2 Ceva Business Overview
  100. 7.17.3 Ceva Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Ceva Veterinary Therapeutics Product Portfolio
  102. 7.17.5 Ceva Recent Developments
  103. 7.18 Boehringer Ingelheim
  104. 7.18.1 Boehringer Ingelheim Company Information
  105. 7.18.2 Boehringer Ingelheim Business Overview
  106. 7.18.3 Boehringer Ingelheim Veterinary Therapeutics Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Boehringer Ingelheim Veterinary Therapeutics Product Portfolio
  108. 7.18.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Veterinary Therapeutics Revenue (2021-2032)
  2. 8.2 North America Veterinary Therapeutics Revenue by Type (2021-2032)
  3. 8.2.1 North America Veterinary Therapeutics Revenue by Type (2021-2026)
  4. 8.2.2 North America Veterinary Therapeutics Revenue by Type (2027-2032)
  5. 8.3 North America Veterinary Therapeutics Revenue Share by Type (2021-2032)
  6. 8.4 North America Veterinary Therapeutics Revenue by Application (2021-2032)
  7. 8.4.1 North America Veterinary Therapeutics Revenue by Application (2021-2026)
  8. 8.4.2 North America Veterinary Therapeutics Revenue by Application (2027-2032)
  9. 8.5 North America Veterinary Therapeutics Revenue Share by Application (2021-2032)
  10. 8.6 North America Veterinary Therapeutics Revenue by Country
  11. 8.6.1 North America Veterinary Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Veterinary Therapeutics Revenue by Country (2021-2026)
  13. 8.6.3 North America Veterinary Therapeutics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Veterinary Therapeutics Revenue (2021-2032)
  2. 9.2 Europe Veterinary Therapeutics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Veterinary Therapeutics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Veterinary Therapeutics Revenue by Type (2027-2032)
  5. 9.3 Europe Veterinary Therapeutics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Veterinary Therapeutics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Veterinary Therapeutics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Veterinary Therapeutics Revenue by Application (2027-2032)
  9. 9.5 Europe Veterinary Therapeutics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Veterinary Therapeutics Revenue by Country
  11. 9.6.1 Europe Veterinary Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Veterinary Therapeutics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Veterinary Therapeutics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Veterinary Therapeutics Revenue (2021-2032)
  2. 10.2 China Veterinary Therapeutics Revenue by Type (2021-2032)
  3. 10.2.1 China Veterinary Therapeutics Revenue by Type (2021-2026)
  4. 10.2.2 China Veterinary Therapeutics Revenue by Type (2027-2032)
  5. 10.3 China Veterinary Therapeutics Revenue Share by Type (2021-2032)
  6. 10.4 China Veterinary Therapeutics Revenue by Application (2021-2032)
  7. 10.4.1 China Veterinary Therapeutics Revenue by Application (2021-2026)
  8. 10.4.2 China Veterinary Therapeutics Revenue by Application (2027-2032)
  9. 10.5 China Veterinary Therapeutics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Veterinary Therapeutics Revenue (2021-2032)
  2. 11.2 Asia Veterinary Therapeutics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Veterinary Therapeutics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Veterinary Therapeutics Revenue by Type (2027-2032)
  5. 11.3 Asia Veterinary Therapeutics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Veterinary Therapeutics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Veterinary Therapeutics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Veterinary Therapeutics Revenue by Application (2027-2032)
  9. 11.5 Asia Veterinary Therapeutics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Veterinary Therapeutics Revenue by Country
  11. 11.6.1 Asia Veterinary Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Veterinary Therapeutics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Veterinary Therapeutics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Veterinary Therapeutics Revenue (2021-2032)
  2. 12.2 SAMEA Veterinary Therapeutics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Veterinary Therapeutics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Veterinary Therapeutics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Veterinary Therapeutics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Veterinary Therapeutics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Veterinary Therapeutics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Veterinary Therapeutics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Veterinary Therapeutics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Veterinary Therapeutics Revenue by Country
  11. 12.6.1 SAMEA Veterinary Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Veterinary Therapeutics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Veterinary Therapeutics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst